Nanjing Dorra Pharmaceutical Technology Co.,Ltd.
About Nanjing Dorra Pharmaceutical Technology Co.,Ltd.
Certifications
Categories
-
Country/Region:China
-
On CPHI since:2015
-
Certificates:2
-
Employees:50 - 99
Company types
Primary activities
Meet us at
CPHI & PMEC China 2026
Shanghai New International Expo Center
16 Jun 2026 - 18 Jun 2026
CPHI Milan 2026
Fiera Milano, Italy
6 Oct 2026 - 8 Oct 2026
CPHI Middle East 2026
Riyadh Exhibition and Convention Centre, Malham, Saudi Arabia
14 Dec 2026 - 16 Dec 2026
Products from Nanjing Dorra Pharmaceutical Technology Co.,Ltd. (20)
-
Product DexborneolConcentrated
CAS No.464-43-7 In-house -
Product Fosfomycin Trometamol
Fosfomycin Trometamol, the tromethamine salt of fosfomycin, is a broad-spectrum bactericidal antibiotic. It acts by irreversibly inhibiting the early stage of bacterial cell wall synthesis, effective against both Gram-positive and Gram-negative bacteria, with no cross-resistance to other antibiotics. Chara... -
Product Mirogabalin Besylate
Mirogabalin Besylate is the besylate salt of mirogabalin, a novel gabapentinoid prodrug with excellent solubility and bioavailability. It is a potent and selective ligand for the α2δ-1 subunit of voltage-gated calcium channels. By inhibiting the hyperexcitability of voltage-dependent calcium channels in th... -
Product Troxerutin
Venous and arterial returnCosmetic use -
Product Salcaprozate Sodium (SNAC)
SNAC is an absorption enhancer widely used in oral formulations of poorly permeable drugs. It acts by transiently increasing the permeability of the gastrointestinal mucosa, facilitating gastric absorption of macromolecules (e.g., peptides) without damaging the mucosal structure. SNAC has been successfully... -
Product Ethyl 8-bromooctanoate
SNAC Starting Material -
Product Fosfomycin Calcium
Antibacterial
-
Product Fosfomycin Phenylethylamine
Fosfomycin series API -
Product Tranexamic Acid
Bleeding treatment; Skin-brightening -
Product Avobenzone
UVA protection -
Product Agomelatine
Antidepressive -
Product Mianserin Hydrochloride
Antidepressive
Nanjing Dorra Pharmaceutical Technology Co.,Ltd. Resources (3)
-
News CEP of Fosfomycin Trometamol Newly Authorized!
We are proud to announce that our Fosfomycin Trometamol API has officially received EU CEP certification (Certificate No. 2024-168-Rev00) from the EDQM.We warmly invite global partners to connect with us and explore new avenues for collaboration. -
Video Company Video
Dorrapharma is engaged in R&D, manufacture and market of intermediates, APls (Active Pharmaceutical Ingredients) and formulations. We own the core technology advantage in the professional area of bromination, enzyme/metalcatalyzed, nitration and hydrogenation, and obtain multiple core patents for invention. We stick to raising the value both for the company and customers, and devote ourselves completely to the technology innovation and brand build and make every effort to foster the core competence for the company with the company mission of a leading pharmaceutical integrated operator with its core competitive advantage in global market.
-
Brochure Dorra Product Lists
Commercialized and Under-Development Pipline












